Two plasma proteins, vitamin D-binding protein (actin monomer sequestrant) and gelsolin (actin polymer severing), have been found in association with actin in plasma from ill humans and during experimental injury. In vitro, these are the only plasma proteins that display a high affinity for actin. We infused increasing amounts of globular actin intravenously to rats to evaluate its disposition in plasma and tissues. Intravascular filament formation, microthrombi, and endothelial injury were observed, especially in the pulmonary circulation. These pathological changes were not observed when the globular actin in the infusate had been preincubated with the vitamin D-binding protein in vitro. Complexes of actin with both proteins were found in the plasma, suggesting a saturable, plasma actin-binding system in vivo. Our findings suggest that in vivo saturation of these proteins' actin-binding capacities may serve as a paradigm for pulmonary vascular disorders seen during widespread tissue trauma and cell lysis.
Actin, as the major protein ofthe microfilament system, plays important roles in cell structure and motility. Many intracellular substances are recognized to influence the monomeric or globular (G-actin) and the polymeric or fibrous (F-actin) forms of the protein. At physiological salt concentrations, the formation of F-actin is favored, although the intracellular balance ofactin moieties is thought to be regulated by various actin-binding proteins that can influence its polymerization and depolymerization (1) (2) (3) (4) (5) .
Plasma salt concentrations also favor actin filament formation, and plasma actin-binding proteins are recognized to influence actin behavior, leading to the hypothesis that an actin-scavenger system exists (6) (7) (8) (9) (10) (11) . The plasma vitamin D-binding protein (DBP), or Gc-globulin, is a 58-kDa polypeptide that exhibits high-affinity (Kd = 10-9 M) and highcapacity (5 x 10-6 M) binding of actin monomers (12, 13) . Another protein, gelsolin, has been identified in plasma and tissues (11, (14) (15) (16) . Gelsolin can sever actin filaments, and bind two or three molecules of G-actin (17, 18) . The complementary features of monomer sequestration and filament severing may, therefore, constitute an effective mechanism whereby actin can be inhibited from polymerization as well as depolymerized in the circulation. In human (19) (20) (21) (22) and experimental (23) conditions characterized by extensive tissue injury, actin-DBP and actin-gelsolin complexes have been found in plasma. The intravenous injection of small amounts of actin into animals results in its association with these two plasma proteins (24) (25) (26) , further suggesting their roles in a putative mechanism for protection against the formation, growth, and perseverance of circulating microfilaments. In the present studies, we tested the hypothesis that a plasma actin-scavenger system would protect animals from increasing amounts of infused G-actin until the actin-binding capacity was saturated.
MATERIALS AND METHODS
Materials. Rabbit skeletal muscle G-actin was prepared in 0.01 M Tris/0.2 mM CaC12/0.5 mM sodium ATP, pH 7.5 (G-actin buffer) (27) . After gel filtration on a 1.1 x 60 cm column of Ultra-Gel AcA44 (LKB) equilibrated in the same buffer, the G-actin was concentrated on Amicon membranes to provide solutions containing the protein at 3-9.33 mg/ml (28) . The actin solutions were used within 10 hr of their preparation. Preparations of 1251I-labeled G-actin (1251_ G-actin) (25, 29) and fluorescent G-actin (30) were also utilized. The radiolabeled and fluorescent actin preparations were shown to polymerize and sediment with unlabeled G-actin in the presence of 100 mM KCI and 2 mM MgCl2, as well as bind to purified DBP. Reference murine plasma gelsolin and rabbit antibody to murine gelsolin were kindly provided by J. A. Cooper (Washington University School of Medicine, Saint Louis). Fluorescein isothiocyanate-phalloidin was purchased from Molecular Probes.
Animal Studies. Intravenous infusions of 1-1.5 ml of the G-actin buffer were delivered into the inferior vena cava of 150-to 250-g Wistar rats under barbiturate anesthesia. After a 1-to 2-min infusion, blood was obtained by cardiac puncture or from the abdominal aorta and placed in heparin or heparin-EDTA at 4°C. Tissues were immediately fixed in situ and prepared for light, fluorescent, and electron microscopic histological examinations (see legends to Figs. 2 and 3) . In some experiments, we coinjected 1251I-G-actin (25, 29) or rhodamine-labeled G-actin (30) with the unlabeled G-actin to provide additional markers for plasma and histological analyses. Infusions of the buffer alone or buffer containing 40 mg of albumin were not associated with untoward effects or histopathology in the rats.
Analyses. Plasma samples were layered onto 4.8-ml, 5-20o sucrose gradients prepared in the buffers indicated in the legend to Fig. 1 . The gradient tubes were centrifuged at 4°C for 18 hr at 40,000 rpm on a SW 50.1 rotor in a Beckman L5-50 B ultracentrifuge. Bottom punctures were made to collect fractions that were analyzed for radioactivity, absorbancy at 280 mm, or immunoreactivity.
Enzyme-linked immunosorbent assays for rat DBP (31) and rat gelsolin were carried out with rabbit anti-rat DBP antiserum (25) and the rabbit anti-murine gelsolin antiserum that was found to cross-react with rat gelsolin (32) . Microtiter plates were coated with reference proteins or sucrose gradient aliquots prior to the addition of rabbit anti-rat DBP or rabbit anti-gelsolin antiserum diluted in 1% gelatin/Trisbuffered saline, pH 7.5. Horseradish peroxidase-labeled goat anti-rabbit antibody (Bio-Rad) was added and color development was effected with o-phenylenediamine in citrate buffer with H202. Wells were analyzed in a Bio-Rad spectrophotometer at 450 mm.
RESULTS
After infusions of 3, 5, or 7 mg of 0-actin, no untoward effects were observed in these rats. Plasma samples revealed all of the G-actin to be complexed to DBP, with no evidence of G-actin alone or actin oligomers ( Fig. 1 A and clusters of developed silver grains in the lumina of pulmonary arterioles of rats receiving the 14-mg dose along with G-actin ( Fig. 2A) . At higher magnification, platelet microthrombi (Fig. 2B) (Fig. 3 A and B) or renal tissue. In the larger arterial vessels of the lung some of the injected actin was in a fibrous form (Fig. 3 C and D) , and in the alveolar capillary beds there was a high concentration of injected rhodamine actin in a polymerized form (Fig. 3 E and F from a direct effect of actin polymerization or indirectly as a consequence of hemodynamic changes and liberation of vasoactive substances from platelets and leukocytes trapped in microthrombi (37) (38) (39) .
Since the concentration of actin in the cytoplasm is several hundred micromolar, a high-capacity plasma-binding system may be protective in all but the most extensive and rapid occurrences of cell lysis. Impaired circulation, however, would compromise such a system. Together, DBP and gelsolin appear to provide >10 ,gM capacity to "neutralize" actin in its monomer and polymeric forms. It is of considerable interest that, in studies of >75,000 subjects, a deficiency of DBP is unknown, lending support to the concept that deletion of the DBP gene is a lethal mutation. Although binding of vitamin D sterols is the other known activity of DBP, the concentration (12) and clearance (40) of DBP are not apparently influenced by vitamin D supply or metabolism. Recent studies of the DBP genes in man and rat have revealed strong homologies with the albumin and a-fetoprotein genes (41, 42) . The ancestral nature and the constitutive expression of the DBP gene may also be related to its product's role in the plasma actin-scavenger mechanism.
Several other studies have reported actin-binding proteins in plasma. In addition to actin antibodies, however, most of these appear to describe depolymerizing or severing (gelsolin or brevin) activities or monomer sequestrants (DBP) or both (10, 15, (43) (44) (45) . Gelsolin has been identified to be a product of several tissues with a tissue and plasma form, and its activities on F-actin are enhanced in the presence ofDBP (13, 46) . The actin-binding activity ofDBP most closely resembles that of the intracellular protein, profilin, but at 1000 times higher affinity (47, 48) .
Minor portions of the plasma DBP and gelsolin appeared in uncomplexed forms in samples that contained polymerized actin (Fig. 1D) that was identified by phalloidin staining. We think that our samples from the left ventricle and abdominal aorta may have reflected an actin occupancy of plasma less pronounced than that likely to have been present in the vena cava, right heart, and pulmonary arteries. Since our studies only included G-actin infusions, they would not faithfully simulate events after cell lysis in vivo. Currently available information, however, appears to suggest that our findings identify a protective system (49, 50), operative during pathophysiological conditions. Cooper (Washington University) generously provided the murine gelsolin and rabbit anti-gelsolin. We are grateful to M. Kowalski and
